In a new job - April 23, 2018
Oncopeptides appoints clinical advisory board
The aim is to identify development opportunities both with Ygalo within the planned first indication, new indications and for the further development of Oncopeptides’ pipeline. Professor Paul G. Richardson, MD, will be chairman of this clinical advisory board. The other members are Dr. Lori A Kunkel, MD, Professor Axel Glasmacher, MD, and Dr. Christian Jacques, […]
In a new job - April 17, 2018
Zelluna appoints new CTO and Head of project management
The Norwegian biotech company announces the appointment of Arjan Roozen as chief technology officer (CTO). “Zelluna appointed Arjan specifically for his wide-ranging knowledge in key areas of cell therapy product manufacturing,” said Miguel Forte, CEO, Zelluna. “Arjan’s experience, acquired on both sides of the Atlantic, will prove invaluable for Zelluna in its immediate focus of […]
Biotech Business - April 13, 2018
Nordic Nanovector CEO steps down
Luigi Costa will step down as Chief Executive Officer by mutual agreement with the Board of Directors. “Nordic Nanovector has recently taken a significant hit to its market valuation and credibility with the Norwegian investment community. As CEO, I have to take full responsibility for this. For the good of the company, its employees and […]
In a new job - April 13, 2018
Targovax appoints new board member
The company announces the appointment of Catherine Wheeler MD to the Targovax Board of Directors. “We are delighted to welcome Catherine, she brings extensive international oncology expertise and insights that will further strengthen the Board. She has had a long and distinguished career and has significant experience of bringing innovative oncology treatments to market that […]
In a new job - April 4, 2018
New Chief Commercial Officer at TFS International
The company announces that Dr Andrew Copestake has accepted the position of Chief Commercial Officer and Executive Vice President, Global Business Development. Copestake is an entrepreneurial, commercially focused, senior executive with over 25 years’ experience in the pharmaceutical, biotechnology and CRO industry. His most recent role was with Julius Clinical, a science-driven CRO based in […]
Business article - March 31, 2018
New CEO of Industrifonden
David Sonnek has been appointed new CEO of the Nordic venture capital firm Industrifonden. “Industrifonden is recognized in the industry as a qualified investor and long-term partner to entrepreneurs, and has an incredibly important role within Nordic venture capital. I feel excited and honored for the opportunity to work alongside a stellar team as well […]
